Affordable Care Act Streamlined surveillance for ventilator-associated pneumonia: Reducing burden and demonstrating preventability; and Prevention and Public Health Fund

 

Ventilator-associated pneumonia (VAP) is one of the most common and deadly healthcare-associated infections (HAIs). Program activities under this funding will facilitate a study to demonstrate the utility and relevance of sVAP and promote acceptance of sVAP within the critical care community. Implementation of a new, reliable, valid, clinically credible and potentially automatable VAP surveillance definition will provide the foundation for national surveillance and prevention efforts and for pay-for-reporting and pay-for-performance programs, leading to improved patient safety and fewer complications for patients needing mechanical ventilation. Specifically, the objectives of this project are to: 1. Implement prospective sVAP surveillance in 9 acute-care hospitals currently conducting VAP surveillance using existing National Healthcare Safety Network (NHSN) definitions; 2. Compare the total sVAP surveillance burden to the total burden associated with use of existing NHSN VAP definitions;, and 3. Implement an evidence-based VAP prevention initiative and evaluate sVAP preventability by assessing the association between sVAP rates and prevention measure compliance rates. Nine hospitals currently engaged in NHSN VAP surveillance will be recruited.

Deleted 04/02/2020 (Archived.) 93.540 Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention Cooperative Agreements Not Applicable. This program is authorized under Sections 317, 317(k)(2), 318 and 318B of the Public health Service Act (42 U.S.C. Sections 247b, 247b(k)(2) and 247c), as amended; and the Patient Protection and Affordable Care Act (PL 111-148), Title IV, Sections 4002, (Prevention and Public Health Fund) for expanded and sustained national investment in prevention and public health programs, IV U.S.C 4002. Eligible applicants include recipients funded under the CDC Prevention Epicenters Program (CI11-001):
a. Chicago Prevention Epicenter
b. Duke University Prevention Epicenter
c. Harvard/Irvine Prevention Epicenter
d. University of Pennsylvania Prevention Epicenter
e. Washington University Prevention Epicenter. State and local health departments, U.S. Territories, and the general public. Allowable costs will be determined in accordance with OMB Circular No. A-87 for State, Local, and Indian Tribal governments. 2 CFR 200, Subpart E - Cost Principles applies to this program. Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372. This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. Applicants must download application forms from www.Grants.gov. Applications must be submitted electronically at www.Grants.gov. If an applicant does not have access to the Internet, or if they have difficulty accessing the forms on-line, contact the CDC Procurement and Grants Office Technical Information Management Section (PGO-TIMS) staff. For this, or further assistance, contact PGO-TIMS: Telephone (770) 488-2700, Email: PGOTIM@cdc.gov.

Successful applicants will receive a Notice of Award (NoA) from the CDC Procurement and Grants Office. The NoA shall be the only binding, authorizing document between the recipient and CDC. The NoA will be signed by an authorized Grants Management Officer and emailed to the program director and a hard copy mailed to the recipient fiscal officer identified in the application.
Unsuccessful applicants will receive notification of the results of the application review by mail. Contact the headquarters or regional office, as appropriate, for application deadlines. From 90 to 120 days. Not Applicable. Renewals will be based upon the conditions in the funding announcement and are subject to the availability of funds under the Patient Protection and Affordable Care Act. Applications will be reviewed for completeness by the Procurement and Grants Office (PGO) staff and for responsiveness jointly by Division of Healthcare Quality Promotion (DHQP), NCEZID and PGO. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicants will be notified the application did not meet submission requirements.

CDC will conduct a review to evaluate complete and responsive applications according to the criteria listed in Section V. Application and Submission Information, subsection “Evaluation Criteria” within the individual funding announcement. Applicants will be notified if their application did not meet program requirements. Project funds may be used for costs associated with planning, data collection, organizing, and the implementation of program elements to build HAI prevention and public health capacity. Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual. The reporting schedule will be based on the requirements listed in the funding announcement. In most cases, funded applicants must provide an interim and annual progress report. Where applicable, the interim progress report is due no less than 90 days before the end of the specified budget period. Where applicable, the Interim Progress Report (IPR) will serve as the non-competing continuation application. Financial Status Reports are required no more than 90 days after the end of the budget period. Final financial status and progress reports are due no later than 90 days after the end of the project period. No cash reports are required. The reporting schedule will be based on the requirements listed in the funding announcement. In most cases, funded applicants must provide an interim and annual progress report. Where applicable, the interim progress report is due no less than 90 days before the end of the specified budget period. Where applicable, the Interim Progress Report (IPR) will serve as the non-competing continuation application. Financial Status Reports are required no more than 90 days after the end of the budget period. Final financial status and progress reports are due no later than 90 days after the end of the project period. No expenditure reports are required. No performance monitoring is required. In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503. Records must be available for review or audit by appropriate officials of the Federal agency, pass-through entity, and General Accounting Office (GAO). The grantee is to also ensure that the sub-recipients receiving CDC funds also meet these requirements (if total Federal grant or grants funds received exceed $500,000). The grantee should include this requirement in all sub-recipient contracts. Financial records, supporting documents, statistical records, and all other records pertinent to the program shall be retained for a minimum of 3 years, or until completion and resolution of any audit in process or pending resolution. In all cases records must be retained until resolution of any audit questions. Property records must be retained in accordance with 45 CFR 92.42. This program has no statutory formula.
This program has no matching requirements. This program has no matching requirements.
This program does not have MOE requirements. This program does not have MOE requirements. Financial assistance is available for a 18-month budget period. Method of awarding/releasing assistance: lump sum. None. Not applicable. Tiffanee L. Woodard CDC,1600 Clifton Rd.,MS-A31
, Atlanta, Georgia 30333. Phone: 404-639-7093. Fax: 406-639-4046. No Data Available 75-0943-0-1-551. (Cooperative Agreements) FY 14 $0; FY 15 est $0; and FY 16 Estimate Not Available - Program has added $30,000 (non-ACA funds) in FY12 to reinstate a research aim from the intial proposal. The project period is the same and the total funding provided for this project is now $1,574,309. Approximately $1,544,309 in FY 2011 is anticipated to fund 1 application. The award period is 24 months. An applicant may request a project period up to 24 months for a total of $1,544,309 including direct and indirect costs. Not Applicable. Not Applicable.